In the desperate scramble for protective gear and other equipment, politically connected companies reaped billions
How an inadvertent error by Pfizer could improve the supply of the Covid-19 vaccine to more people
The Trump administration is negotiating a deal to free up supplies of raw materials to help Pfizer produce tens of millions of additional doses of its COVID-19 vaccine for Americans. It could at least partially remedy a looming shortage that the administration itself arguably helped create
Tens of millions of desperate migrant workers who were stranded without work or food after the nationwide lockdown took government-provided emergency trains to go back to their home villages. They became the virus trains.
The sports economy has been ravaged by the pandemic. The absence of live fans alone has forced the thousands of people who once put on games at these venues out of work, including ticket agents, hot dog vendors, bartenders and janitors
When all is said and done, making the vaccine might turn out to have been the easy part
As Britons rolled up their sleeves for the start of a coronavirus vaccine campaign, he was the second to get a shot
Volunteers who took the jab give Forbes India a peek into their apprehensions and the aftermath
The Food and Drug Administration's first analysis of the clinical trial data also found that the coronavirus vaccine worked well regardless of a volunteer's race, weight or age
About 20 million people will be innoculated over two doses, but logistical challenges remain
What if you've already had Covid-19 — do you still need a vaccine? Experts tackle questions about vaccine immunity